Atlas Trials

Human Immunodeficiency Virus Infection

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Human Immunodeficiency Virus Infection

RecordFirmDate
A Drug-drug Interaction Study of SHR2150 on Healthy Chinese Volunteers (NCT05141422)Jiangsu HengRui Medicine Co., Ltd.2021-12-13
Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids (NCT03284645)Obafemi Awolowo University2017-12-22
Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men (NCT03143205)University of California, San Francisco2017-05-05
DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants (NCT02817451)Sanofi Pasteur, a Sanofi Company2016-07-14
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) (NCT02738138)AbbVie2016-05-17
The Effect of an Enhanced Rice Bran Nutritional Supplement in HIV (NCT02214173)University of Miami2015-01-01
A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection (NCT01939197)AbbVie2013-08-30
Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART (NCT01869634)University of California, Davis2013-06-01
A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects (NCT01738555)RFS Pharma, LLC2013-04-01
Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults (NCT01791465)Vanderbilt University2013-03-01
A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects. (NCT01737359)RFS Pharma, LLC2012-12-01
Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program (NCT01662336)AbbVie (prior sponsor, Abbott)2012-06-01
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing (NCT01447680)G & W Laboratories Inc.2011-08-01
Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection (NCT01328158)AbbVie (prior sponsor, Abbott)2011-06-01
Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets) (NCT01383005)AbbVie (prior sponsor, Abbott)2011-06-01
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL) (NCT00711009)Abbott2008-07-01
Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men (NCT01490359)University of Pennsylvania2007-11-01
Long-term Effectiveness and Safety in Hepatitis-co-infected Patients (NCT01153269)Abbott2001-05-01

Track Human Immunodeficiency Virus Infection automatically

Every clearance here is in the API, with alerts when new ones post.